Nucleoporin NUP153 Phenylalanine-Glycine Motifs Engage a Common Binding Pocket within the HIV-1 Capsid Protein to Mediate Lentiviral Infectivity
Open accessThe DOI matches its Crossref record; 90 of the 91 references it cites were found in a registry or an index.
Abstract
Lentiviruses can infect non-dividing cells, and various cellular transport proteins provide crucial functions for lentiviral nuclear entry and integration. We previously showed that the viral capsid (CA) protein mediated the dependency on cellular nucleoporin (NUP) 153 during HIV-1 infection, and now demonstrate a direct interaction between the CA N-terminal domain and the phenylalanine-glycine (FG)-repeat enriched NUP153 C-terminal domain (NUP153(C)). NUP153(C) fused to the effector domains of the rhesus Trim5α restriction factor (Trim-NUP153(C)) potently restricted HIV-1, providing an intracellular readout for the NUP153(C)-CA interaction during retroviral infection. Primate lentiviruses and equine infectious anemia virus (EIAV) bound NUP153(C) under these conditions, results that correlated with direct binding between purified proteins in vitro. These binding phenotypes moreover correlated with the requirement for endogenous NUP153 protein during virus infection. Mutagenesis experiments concordantly identified NUP153(C) and CA residues important for binding and lentiviral infectivity. Different FG motifs within NUP153(C) mediated binding to HIV-1 versus EIAV capsids. HIV-1 CA binding mapped to residues that line the common alpha helix 3/4 hydrophobic pocket that also mediates binding to the small molecule PF-3450074 (PF74) inhibitor and cleavage and polyadenylation specific factor 6 (CPSF6) protein, with Asn57 (Asp58 in EIAV) playing a particularly important role. PF74 and CPSF6 accordingly each competed with NUP153(C) for binding to the HIV-1 CA pocket, and significantly higher concentrations of PF74 were needed to inhibit HIV-1 infection in the face of Trim-NUP153(C) expression or NUP153 knockdown. Correlation between CA mutant viral cell cycle and NUP153 dependencies moreover indicates that the NUP153(C)-CA interaction underlies the ability of HIV-1 to infect non-dividing cells. Our results highlight similar mechanisms of binding for disparate host factors to the same region of HIV-1 CA during viral ingress. We conclude that a subset of lentiviral CA proteins directly engage FG-motifs present on NUP153 to affect viral nuclear import.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


![Figure 3 Diverse lentiviruses bind NUP153C. (A) Transduction efficiencies of retroviral GFP reporter viruses in Trim-NUP153C expressing cells normalized to infection in mock transduced cells, which were set to 100%. Results are the geometric mean of 4 experiments, with error bars denoting 95% confidence intervals. (B) HA-NUP153C expressed in 293T cells was pulled down by the indicated his-tagged retroviral CAN proteins. Captured proteins resolved by SDS-PAGE were western blotted with antibody 3F10 alongside a standard curve of input protein. The results are an average of 5 experiments, with error bars denoting 95% confidence intervals. A representative western blot is shown. (C) SYPRO Ruby detection of retroviral CAN pull-down of purified NUP153C. The results are an average of two experiments, with error bars denoting standard error; one representative gel is shown. (D) (left) Retroviral infectivities in HOS cells knocked down for NUP153 expression as compared to cells treated with a non-targeting short interfering (si) RNA control [19]. The results are the geometric mean of at least 4 experiments, with error bars denoting 95% confidence intervals. (right) Western blot detection of control or NUP153 knockdown HOS cells with antibody mab414, which also detects NUP358. (E) Scatter plot comparing relative retroviral infectivities under each condition.](https://figures.cochat.ai/paper-figures/ed918781228e48e0ab7e509b190f5345/nucleoporin-nup153-phenylalanine-glycine-motifs-engage-a-common-binding-pocket-figure-3.jpg)









Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“HIV-1 nuclear import is mediated via the viral capsid, which interacts directly with several components of the cellular nuclear import machinery, including the nuclear pore complex components Nup153 and Nup358 (REF.76–78).”
From Structure and function of retroviral integrase (2022) · cites this paper as [78]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“recent studies have shown that HIV-1 CA can enter the nucleus of nondividing cells with the help of host factors like the cleavage and polyadenylation specificity factor 6 (CPSF6) and nuclear pore complex (NPC) proteins, NUP153 and NUP358 (Matreyek et al. 2013, Buffone et al. 2018, Bejarano et al. 2019, Burdick et al. 2020, Dharan et al. 2020, Selyutina et al. 2020, Zila et al. 2021).”
From Beyond reverse transcription: molecular mechanisms and emerging paradigms in retroviral replication (2026) · cites this paper as Matreyek et al. 2013
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Cleavage and polyadenylation specificity factor 6 (CPSF6), which is a component of the cellular pre-mRNA cleavage and polyadenylation machinery79, binds the same region of capsid as Nup153 (REF.78,80).”
From Structure and function of retroviral integrase (2022) · cites this paper as [78]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The cytoplasmic body component TRIM5α restricts HIV-1 infection in Old World monkeys
Stremlau, M., Owens, C. M., Perron, M. J., Kiessling, M., Autissier, P., & Sodroski, J. (2004) · Nature · doi:10.1038/nature02343 · Cited by 1,816
The Role of Mononuclear Phagocytes in HTLV-III/LAV Infection
Gartner, S., Markovits, P., Markovitz, D. M., Kaplan, M. H., Gallo, R. C., & Popovic, M. (1986) · Science · doi:10.1126/science.3014648 · Cited by 1,807
Identification of host proteins required for HIV infection through a functional genomic screen
Brass, A. L., Dykxhoorn, D. M., Benita, Y., Yan, N., Engelman, A., Xavier, R. J., Lieberman, J., & Elledge, S. J. (2008) · Science · doi:10.1126/science.1152725 · Cited by 1,449 · cited 1×
“…been shown to participate in HIV-1 nuclear import, with perhaps the most promising candidates emerging from a series of genome-wide RNA interference (RNAi) screens; factors identified in more than one of these screens include transportin-3 (TNPO3 or TRN-SR2), NUP358 (RANBP2), and NUP153 [15–17].”
BackgroundSelf-citationGlobal Analysis of Host-Pathogen Interactions that Regulate Early-Stage HIV-1 Replication
König, R., Zhou, Y., Elleder, D., Diamond, T. L., Bonamy, G. M. C., Irelan, J. T., Chiang, C.-Y., Tu, B. P., De Jesus, P. D., Lilley, C. E., et al. (2008) · Cell · doi:10.1016/j.cell.2008.07.032 · Cited by 960
Integration of murine leukemia virus DNA depends on mitosis.
Roe, T., Reynolds, T. C., Yu, G., & Brown, P. O. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05858.x · Cited by 921
Heinzinger, N. K., Bukinsky, M. I., Haggerty, S. A., Ragland, A. M., Kewalramani, V, Lee, M. A., Gendelman, H. E., Ratner, L., Stevenson, M., & Emerman, M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.15.7311 · Cited by 854 · cited 1×
“While relatively intact cores enter the cell upon viral-cell membrane fusion, little if any CA remains associated with the PIC within the nucleus [33–37].”
BackgroundMature HIV-1 capsid structure by cryo-electron microscopy and all-atom molecular dynamics
Zhao, G., Perilla, J. R., Yufenyuy, E. L., Meng, X., Chen, B., Ning, J., Ahn, J., Gronenborn, A. M., Schulten, K., Aiken, C., et al. (2013) · Nature · doi:10.1038/nature12162 · Cited by 801
Lewis, P. F., & Emerman, M. (1994) · Journal of Virology · doi:10.1128/jvi.68.1.510-516.1994 · Cited by 797
Willey, R. L., Smith, D. H., Lasky, L. A., Theodore, T. S., Earl, P. L., Moss, B., Capon, D. J., & Martin, M. A. (1988) · Journal of Virology · doi:10.1128/jvi.62.1.139-147.1988 · Cited by 751
Stremlau, M., Perron, M., Lee, M., Li, Y., Song, B., Javanbakht, H., Diaz-Griffero, F., Anderson, D. J., Sundquist, W. I., & Sodroski, J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509996103 · Cited by 739
Research works printed but not linked: 1
- N Loewen, 2003, FIV Vectors, Method Mol Biol, 229, 251
Cited by
Items 201–293 of 293
CPSF6 promotes HIV-1 preintegration complex function
Chaudhuri, E., Jang, S., Chakraborty, R., Radhakrishnan, R., Arnarson, B., Prakash, P., Cornish, D., Rohlfes, N., Singh, P. K., Shi, J., et al. (2025) · Journal of Virology · doi:10.1128/jvi.00490-25 · Cited by 8
Self-citationLenacapavir allosterically remodels the HIV-1 capsid
dos Santos, N. F. B., Lewis, J. A., Hansen, M., Pereira, M. J. B., Christensen, D. E., Sundquist, W. I., Ganser‐Pornillos, B. K., & Pornillos, O. (2026) · Science Advances · doi:10.1126/sciadv.aed8384 · Cited by 8
Dias, T. L., Mamede, I., de Toledo, N. E., Queiroz, L. R., de Castro, Í. M. S., Polidoro, R. B., Del‐Bem, L., Nakaya, H. I., & Franco, G. R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25115671 · Cited by 9
HIV capsids: orchestrators of innate immune evasion, pathogenesis and pandemicity
Morling, K. L., ElGhazaly, M., Milne, R. S. B., & Towers, G. J. (2025) · Journal of General Virology · doi:10.1099/jgv.0.002057 · Cited by 8
Singh, S. P., Raja, S., & Mahalingam, S. (2020) · Molecular Biology of the Cell · doi:10.1091/mbc.e19-08-0438 · Cited by 8
The HIV-1 Capsid-Targeted Inhibitor GSK878 Alters Selection of Target Sites for HIV DNA Integration
Marquis, K. A., Everett, J. K., Cantu, A., McFarland, A. G., Sherrill-Mix, S. A., Krystal, M., Parcella, K. E., Gillis, E. P., Fridell, R. A., & Bushman, F. D. (2023) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2022.0161 · Cited by 8
The Early Bird Catches the Worm - Can Evolution Teach us Lessons in Fighting HIV?
Schaller, T., & Herold, N. (2016) · Current HIV Research · doi:10.2174/1570162x14999160224094914 · Cited by 8
The small‐molecule 3G11 inhibits HIV‐1 reverse transcription
Opp, S., Fricke, T., Shepard, C., Kovalskyy, D., Bhattacharya, A., Herkules, F., Ivanov, D. N., Kim, B., Valle‐Casuso, J. C., & Diaz‐Griffero, F. (2016) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12886 · Cited by 8
Long, M., Cantrelle, F., Robert, X., Boll, E., Sierra, N., Gouet, P., Hanoulle, X., Álvarez, G., & Guillon, C. (2021) · Biochemistry · doi:10.1021/acs.biochem.1c00228 · Cited by 8
Targeting nuclear proteins for control of viral replication
Meng, W., Wang, X., & Wang, H. R. (2019) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2018.1553848 · Cited by 9
Luo, X., Wei, Q., Xie, L., Chen, N., Gu, B., Xu, J., Jiang, X., Zuo, X., Zhao, H., Liu, X., et al. (2025) · Clinical and Translational Medicine · doi:10.1002/ctm2.70388 · Cited by 7
Nuclear pore passage of the HIV capsid is driven by its unusual surface amino acid composition
Fu, L., Cheng, S., Riedel, D., Kopecny, L., Schuh, M., & Görlich, D. (2025) · Nature Structural & Molecular Biology · doi:10.1038/s41594-025-01684-5 · Cited by 7
Cook, M., Freniere, C., Wu, C., Lozano, F., & Xiong, Y. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115245 · Cited by 7
Considerations for capsid-targeting antiretrovirals in pre-exposure prophylaxis
McFadden, W. M., Færch, M., Kirby, K. A., Dick, R. A., Torbett, B. E., & Sarafianos, S. G. (2025) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2025.01.013 · Cited by 7
Cell Type-Dependent Escape of Capsid Inhibitors by Simian Immunodeficiency Virus SIVcpz
Twizerimana, A. P., Scheck, R., Becker, D., Zhang, Z., Wammers, M., Avelar, L. A. A., Pflieger, M., Häussinger, D., Kurz, T., Gohlke, H., et al. (2020) · Journal of Virology · doi:10.1128/jvi.01338-20 · Cited by 7
Dick, A., Meuser, M. E., & Cocklin, S. (2022) · Biomolecules · doi:10.3390/biom12050695 · Cited by 7
Defining the HIV Capsid Binding Site of Nucleoporin 153
Li, S., Patel, J. S., Yang, J., Crabtree, A., Rubenstein, B. M., Lund-Andersen, P. K., Ytreberg, F. M., & Rowley, P. A. (2022) · mSphere · doi:10.1128/msphere.00310-22 · Cited by 9
The HIV-1 Capsid: More than Just a Delivery Package
James, L. C. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-14741-9_4 · Cited by 9
Rodriguez, Z. K., Andino-Moncada, J. R., Buth, S. A., Mehrani, A., Ranaweera, A., Shi, J., de Andrade, L. R., Singh, S. P., Strutzenberg, T. S., Marin, M., et al. (2025) · ACS Nano · doi:10.1021/acsnano.5c06724 · Cited by 6
Cyclophilin A Regulates Tripartite Motif 5 Alpha Restriction of HIV-1
Wang, T., Becker, D., Twizerimana, A. P., Luedde, T., Gohlke, H., & Münk, C. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26020495 · Cited by 6
Barateau, V., Nguyen, X.-N., Bourguillault, F., Berger, G., Cordeil, S., & Cimarelli, A. (2015) · Journal of Virology · doi:10.1128/jvi.03315-14 · Cited by 6
Zgheib, S., Lysova, I., Réal, É., Dukhno, O., Vauchelles, R., Pires, M., Anton, H., & Mély, Y. (2019) · Scientific Reports · doi:10.1038/s41598-018-37150-0 · Cited by 6
Rapid In Vitro Evaluation of Antiretroviral Barrier to Resistance at Therapeutic Drug Levels
Mulato, A. S., Hansen, D., Thielen, A., Porter, D., Stepan, G. J., White, K., Daeumer, M., Cihlář, T., & Yant, S. R. (2016) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2016.0071 · Cited by 6
A DNA-origami nuclear pore mimic reveals nuclear entry mechanisms of HIV-1 capsidPreprint
Shen, Q., Xu, C., Jang, S., Xiong, Q., Devarkar, S. C., Tian, T., Bedwell, G. J., Tripler, T. N., Hu, Y., Yuan, S., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.08.10.245522 · Cited by 6
Self-citationBeyond reverse transcription: molecular mechanisms and emerging paradigms in retroviral replication
Jehad, M. A., Ali, L. M., Pillai, V. N., Prabhu, S. G., Mustafa, F., & Rizvi, T. A. (2026) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuaf066 · Cited by 5
“In addition, recent studies have shown that HIV-1 CA can enter the nucleus of nondividing cells with the help of host factors like the cleavage and polyadenylation specificity factor 6 (CPSF6) and nuclear pore complex (NPC) proteins, NUP153 and NUP358 (Matreyek et al. 2013 , Buffone et al. 2018 , Bejarano et al. 2019…”
Comparative analysis of retroviral Gag-host cell interactions: focus on the nuclear interactome
Lambert, G. S., Rice, B. L., Maldonado, R. J. K., Chang, J., & Parent, L. J. (2024) · Retrovirology · doi:10.1186/s12977-024-00645-y · Cited by 5
Preclinical virology profiles of the HIV-1 capsid inhibitors VH4004280 and VH4011499
Wang, C., Huang, H., Valera, L., Parcella, K. E., Iwuagwu, C. I., McAuliffe, B., Falk, P. J., O’Boyle, D. R., Rose, R. E., Padilla, R., et al. (2025) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00309-25 · Cited by 5
Nuclear restriction of HIV-1 infection by SUN1
Persaud, M., Selyutina, A., Buffone, C., Opp, S., Donahue, D. A., Schwartz, O., & Diaz‐Griffero, F. (2021) · Scientific Reports · doi:10.1038/s41598-021-98541-4 · Cited by 5
Decoding the biogenesis of HIV-induced CPSF6 puncta and their fusion with nuclear speckles
Tomasini, C., Cuche, C., Ay, S., Collard, M., Cui, B., Rashid, M., Bhattacharjee, S., Tello-Rubio, B., Buchrieser, J., Luchsinger, C., et al. (2026) · eLife · doi:10.7554/elife.103725.3 · Cited by 4
Flick, H., Venbakkam, A., Singh, P. K., Layish, B., Huang, S., Radhakrishnan, R., Kvaratskhelia, M., Engelman, A., & Kane, M. (2025) · mBio · doi:10.1128/mbio.02646-24 · Cited by 4
Self-citationHalambage, U. D., Wong, J. P., Melancon, B. J., Lindsley, C. W., & Aiken, C. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00646-15 · Cited by 4
Sahani, R. L., Akther, T., Cilento, M. E., Castaner, A. E., Zhang, H., Kirby, K. A., Xie, J., Sarafianos, S. G., & Wang, Z. (2021) · RSC Medicinal Chemistry · doi:10.1039/d1md00292a · Cited by 4
A Tag‐Free Platform for Synthesis and Screening of Cyclic Peptide Libraries
Bruce, A., Adebomi, V., Czabala, P., Palmer, J. M., McFadden, W. M., Lorson, Z. C., Slack, R. L., Bhardwaj, G., Sarafianos, S. G., & Raj, M. (2024) · Angewandte Chemie · doi:10.1002/ange.202320045 · Cited by 4
Nup358 and Nup153 Facilitate nuclear import of BmNPV nucleocapsids in Bombyx mori cells
Yin, K., Zhang, T., Huang, J., & Hao, B. (2025) · Journal of Invertebrate Pathology · doi:10.1016/j.jip.2025.108318 · Cited by 3
Gruenke, P. R., Mayer, M. D., Aneja, R., Schulze, W. J., Song, Z., Burke, D. H., Heng, X., & Lange, M. J. (2024) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.3c00708 · Cited by 4
Keeping your armour intact: How HIV‐1 evades detection by the innate immune system
Maelfait, J., Seiradake, E., & Rehwinkel, J. (2014) · BioEssays · doi:10.1002/bies.201400019 · Cited by 6
Quinazolinone-based subchemotypes for targeting HIV-1 capsid protein: design and synthesis
Akther, T., McFadden, W. M., Zhang, H., Kirby, K. A., Tedbury, P. R., & Wang, Z. (2024) · Medicinal Chemistry Research · doi:10.1007/s00044-024-03305-0 · Cited by 3
Mx Oligomer: A Novel Capsid Pattern Sensor?
Kong, J., Ma, M., He, S., & Qin, X. (2016) · Future Microbiology · doi:10.2217/fmb-2016-0004 · Cited by 3
Nuclear Pore Complexes, Genome Organization and HIV-1 Infection
Nunzio, F. D. (2018) · Springer eBooks · doi:10.1007/978-3-319-71614-5_8 · Cited by 4
VRK1 co-delivery mitigates DNA clustering by BAF in TFAMoplex transfection
Greitens, C., Maurer, P., Balkan, S., Leroux, J., & Burger, M. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.102588 · Cited by 2
Álvarez, G., van Pul, L., Robert, X., Artía, Z., van Nuenen, A. C., Long, M., Sierra, N., Porcal, W., Kootstra, N. A., & Guillon, C. (2022) · BMC Pharmacology and Toxicology · doi:10.1186/s40360-022-00581-7 · Cited by 2
CRISPR-Cas-Based Gene Therapy to Target Viral Infections
Hussein, M., Berkhout, B., & Herrera-Carrillo, E. (2022) · Springer eBooks · doi:10.1007/978-3-030-93333-3_5 · Cited by 2
Artía, Z., Guillon, C., Robert, X., Granzella, M., Segovia, A. C., Truong, H. H., Álvarez, G., Corvo, I., & Randall, L. M. (2025) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2025.151572 · Cited by 2
The Long Terminal Repeat Retrotransposons Tf1 and Tf2 of Schizosaccharomyces pombe
Esnault, C., & Levin, H. L. (2015) · ASM Press eBooks · doi:10.1128/9781555819217.ch43 · Cited by 2
Nup153 Unlocks the Nuclear Pore Complex for HIV-1 Nuclear Import in Non-Dividing CellsPreprint
Opp, S., Martínez‐López, A., Fricke, T., Buffone, C., Severgnini, M., Cifola, I., Frabetti, S., Skorupka, K. A., Zadrozny, K. K., Ganser‐Pornillos, B. K., et al. (2018) · SSRN Electronic Journal · doi:10.2139/ssrn.3155897 · Cited by 2
Barnett, M., Sun, L., Xu, S., Liu, X., Zhan, P., & Goldstone, D. C. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.08.16.553511 · Cited by 2
Gao, X., McFadden, W. M., Wen, X., Emanuelli, A., Lorson, Z. C., Zheng, H., Kirby, K. A., & Sarafianos, S. G. (2023) · PubMed · doi:10.1101/2023.11.29.569293
Decoding the biogenesis of HIV-induced CPSF6 puncta and their fusion with the nuclear specklePreprint
Tomasini, C., Cuche, C., Ay, S., Collard, M., Cui, B., Rashid, M., Bhattacharjee, S., Buchrieser, J., Luchsinger, C., Bertelli, C., et al. (2024) · eLife · doi:10.7554/elife.103725.1 · Cited by 2
Effects of GS-CA1 on nuclear envelope-associated early HIV-1 infection steps
Singh, A., Fourcassié, V., dos Santos, K. C. G., Chelbi, H., Mérindol, N., Droit, A., Germain, H., & Berthoux, L. (2025) · Frontiers in Virology · doi:10.3389/fviro.2025.1547176 · Cited by 1
The intersection of viral mimicry and nuclear entry
Dickson, C. F., Phalora, P. K., & Jacques, D. A. (2025) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2025.07.002 · Cited by 1
Zhang, X., Sun, L., Walsham, L., Ma, Y., Ding, D., Wang, M. S., Zhao, F., Zhang, J., Wang, Z., Xu, S., et al. (2026) · MedComm · doi:10.1002/mco2.70746 · Cited by 1
Melčák, I., Slack, R. L., Lorson, Z. C., Castaner, A. E., Ambrus, K., Winkjer, J. S., Kirby, K. A., Dick, R. A., & Sarafianos, S. G. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2534919123 · Cited by 2
Nucleoporins in Retroviral Replication
Monette, A., & Mouland, A. J. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811185-7.00003-0 · Cited by 1
Retroviral Vectors for Gene Therapy of Monogenic Diseases
Yoder, K. E., Rabe, A. J., & Larue, R. C. (2022) · Springer eBooks · doi:10.1007/978-3-030-93333-3_7 · Cited by 1
Structures and functions of the C-Terminal domain of HIV-1 integration
Oladosu, O. (2017) · theses.fr (ABES) · doi:10.70675/ad8059d5z788dz4aafza31dz85b0c784be62 · Cited by 1
Kirby, K. A., McFadden, W. M., Wang, L., Du, H., Zhang, H., Castaner, A. E., Lorson, Z. C., Nafisi, A., Selyutina, A., Luchsinger, C., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.30.696960 · Cited by 1
Studies of Fv1 binding and restriction
Li, H. L. W. (2015) · UCL Discovery (University College London)
Expression, Purification and Characterization of Hiv-1 Capsid Precursor Protein p41
Zhang, Z., Wang, L., Bai, S., Qiao, J., Shen, H., Huang, F., Gao, S., Li, S., Li, S., Gu, Y., et al. (2018) · The Protein Journal · doi:10.1007/s10930-018-9763-0
Nuclear Import: HIV-1 Goes NUPs
Woodward, C. L., Wu, J., & Chow, S. A. (2018) · Springer eBooks · doi:10.1007/978-1-4939-7101-5_85
Tauzin, A. (2020) · theses.fr (ABES) · doi:10.70675/47aaa60dz2c00z416bz83c6z64326da6c3dc · Cited by 1
Nuclear Import: HIV-1 Goes NUPs
Woodward, C. L., Wu, J., & Chow, S. A. (2013) · Springer eBooks · doi:10.1007/978-1-4614-9610-6_85-1
Informatically-informed biochemical characterization of aptamer-protein complexes
Gruenke, P. R. (2022) · MOspace Institutional Repository (University of Missouri) · doi:10.32469/10355/91663
Bhargava, A. (2020) · theses.fr (ABES) · doi:10.70675/ca00319bz6e29z4867z9dc9z1b4306686678
HIV-induced of the nuclear landscape : from phase separation to viral replication
Scoca, V. (2022) · theses.fr (ABES) · doi:10.70675/fbab8533za017z4277zaf40z3efc76772116
Li, S., Lund-Andersen, P. K., Wang, S., Ytreberg, F. M., Naik, M. T., Patel, J. S., & Rowley, P. A. (2025) · Journal of General Virology · doi:10.1099/jgv.0.002104
Decoding the biogenesis of HIV-induced CPSF6 puncta and their fusion with the nuclear specklePreprint
Tomasini, C., Cuche, C., Ay, S., Collard, M., Cui, B., Rashid, M., Bhattacharjee, S., Tello-Rubio, B., Buchrieser, J., Luchsinger, C., et al. (2025) · eLife · doi:10.7554/elife.103725.2
Álvarez, G., van Pul, L., Robert, X., Artía, Z., van Nuenen, A. C., Long, M., Sierra, N., Porcal, W., Kootstra, N. A., & Guillon, C. (2022) · Figshare · doi:10.6084/m9.figshare.20175620
Rôle de la protéine antisens (ASP) dans le cycle de réplication du VIH-1
Houmey, M. A. (2024) · HAL
Understanding Prototype Foamy Virus Integrase Site Selection, Activity, and Stability
Mackler, R. M. (2018) · OhioLink ETD Center (Ohio Library and Information Network)
McFadden, W. M., Kirby, K. A., Lorson, Z. C., Wang, L., Highland, C. M., Harvey, S. R., Brancato, S. G., Castaner, A. E., Du, H., Wysocki, V. H., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.03.19.712970
Contrôle de l’expression du VIH-1 par les complexes associés au facteur de transcription Iws1
Abdouni, A. (2016) · theses.fr (ABES) · doi:10.70675/3cd9a7dfz9792z45edz8f25z0a39f612c0ff
Hassani, Z. M., Goulet, F., Nguyen, D. T., Landry-Voyer, A.-M., Kwiatek, L., Gaudet, S., Boudreault, P., Azad, T., & Bachand, F. (2026) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2026.111415
Caractérisation des voies d’échappement aux inhibiteurs d’intégrase du VIH-1
Thierry, E. (2015) · theses.fr (ABES) · doi:10.70675/602eaec1z5d9az4bb2za08dz10755e91efc2
Caractérisation des fonctions cellulaires du facteur de restriction viral APOBEC3A
Niocel, M. (2017) · theses.fr (ABES) · doi:10.70675/b688234az5bc7z4100zb26ez7528ceb4c3ae
Imaging of intracellular trafficking of the HIV-1 nucleocapsid protein
Lysova, I. (2017) · theses.fr (ABES) · doi:10.70675/84144144z02cbz4d62zb92cz97858cebc61d
Structural rearrangements of the HIV-1 genomic RNA during maturation of the viral particle
Mailler, É. (2017) · theses.fr (ABES) · doi:10.70675/6ce04440z0ddfz4ad2zbbdbzf94bec9b3db0
Étude de l’implication des importines-ß dans l’infection et l’import nucléaire du VIH-1
Machado, A. K. (2016) · theses.fr (ABES) · doi:10.70675/14e394daze14dz46a8zbb34z72aeaed1f3ab
Gentili, M. (2017) · theses.fr (ABES) · doi:10.70675/93617cb4za4e9z4fdez831az0bf2b31aea90
Optimisation de la stratégie de thérapie génique par vecteur lentiviral pour la β-thalassémie
Giorgi, M. (2019) · theses.fr (ABES) · doi:10.70675/041f272dz23faz452bzb352z46cf95acb76d
Hou, Z., & Zhang, P. (2026) · Annual Review of Virology · doi:10.1146/annurev-virology-100424-125355
Mechanistic Insights into HIV-1 Capsid Interactions with CPSF6
Hudait, A., Ghosh, K., & Voth, G. A. (2026) · Viruses · doi:10.64898/2026.09.05.749640
A Historical Account of Retroviral Assembly and Budding
Carter, C. A. (2026) · Annual Review of Virology · doi:10.1146/annurev-virology-100424-011327
Singh, P. (2026) · Harvard Dataverse · doi:10.7910/dvn/udt6uc
Processed HIV-1 integration site datasets from Jurkat cells with capsid mutants
Singh, P. (2026) · Harvard Dataverse · doi:10.7910/dvn/xrkmnr
Jang, S., Radhakrishnan, R., Greenwood, J., Singh, P. K., Bedwell, G. J., Robles‐Sikisaka, R., Routh, A. L., & Engelman, A. (2026) · mBio · doi:10.1128/mbio.02276-26
Self-citationLi, M., Pan, Z., & Guan, Y. (2026) · Animal Research and One Health · doi:10.1002/aro2.70101
Rey, J. S., Peeples, C. A., Macke, A. C., & Perilla, J. R. (2026) · Journal of the American Chemical Society · doi:10.1021/jacs.6c11578
Metadata
- Authors
- Matreyek, K. A., Yücel, S. S., Li, X., & Engelman, A.
- Affiliations
- Harvard University (US)
- Corresponding author
- Engelman, Alan
- Venue
- PLoS Pathogens
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-10-10
- Volume
- 9
- Issue
- 10
- Pages
- e1003693
- ISSN
- 1553-7366 (ISSN-L)
- 1553-7374
- PMC
- PMC3795039
- OpenAlex
- W2120902492
- Cited by
- 280
- References
- 91
- Citations by year
- 2026: 10 · 2025: 30 · 2024: 27 · 2023: 17 · 2022: 18 · 2021: 32 · 2020: 25 · 2019: 21 · 2018: 24 · 2017: 13 · 2016: 23 · 2015: 18 · 2014: 20 · 2013: 2
- FWCI
- 9.64
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Pathogens (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases (AI052014, R01AI052014)
- Topics
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Structure and Function
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Keywords
- Nup153, HIV-1 capsid protein, host-virus protein interaction, equine infectious anemia virus, CPSF6
- MeSH terms
- Binding Sites, Cell Cycle, Cell Line, Cell Nucleus, Humans, Mutation, Protein Binding, HIV-1, HIV Infections, Amino Acid Motifs, Active Transport, Cell Nucleus, Nuclear Pore Complex Proteins, mRNA Cleavage and Polyadenylation Factors, gag Gene Products, Human Immunodeficiency Virus, Hydrophobic and Hydrophilic Interactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.